Boston Scientific (BSX) Depreciation and Depletion (2020 - 2026)

Boston Scientific's Depreciation and Depletion history runs 7 years deep, the most recent figure standing at $29.0 million for Q1 2026.

• In Q1 2026, Depreciation and Depletion rose 7.41% year-over-year to $29.0 million; the TTM figure through Mar 2026 stood at $394.0 million (up 12.89% YoY), while the FY2025 annual figure was $471.0 million, up 14.32% from the prior year.
• Depreciation and Depletion came in at $29.0 million for Q1 2026 at Boston Scientific, down from $137.0 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $137.0 million in Q4 2025 to a low of $27.0 million in Q1 2025.
• A 5-year average of $90.2 million and a median of $93.0 million in 2023 frame the typical range for Depreciation and Depletion.
• Across the five-year window, Depreciation and Depletion grew 17.31% in 2024 and tumbled 70.0% in 2025, its largest moves.
• Boston Scientific's Depreciation and Depletion stood at $95.0 million in 2022, then climbed by 9.47% to $104.0 million in 2023, then increased by 17.31% to $122.0 million in 2024, then advanced by 12.3% to $137.0 million in 2025, then slumped by 78.83% to $29.0 million in 2026.
• According to Business Quant data, Depreciation and Depletion over the past three periods registered $29.0 million, $137.0 million, and $117.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison